Innovation
ASCO 25 Posters
GTC presented abstracts at ASCO 2025 GTC’s posters from the 2025 Convention of the American Society of Clinical Oncology are now available for download. Please
June 3, 2025 10:00 am
Read More »
Press Releases
Summit Health Announces Internalization of GTC’s DNA & RNA Profiling Tests
Summit Health Announces Internalization of GTC’s State-of-The-Art Next Gen Sequencing DNA & RNA Profiling Tests for Tissue and Liquid Biopsy of Solid Tumors and Hematologic
May 20, 2025 4:00 am
Article
GTC featured in OC Business Journal
GTC Expands Cancer Tests to Europe via Partnership By Yuika Yoshida April 7, 2025 Genomic Testing Cooperative (GTC) is expanding into the European market by partnering with
April 16, 2025 12:12 pm
Genomic Testing Cooperative Receives UKCA Mark for its Portfolio of Hematology, Solid Tumors and Liquid Biopsy Profiles covering DNA and RNA
Lake Forest, CA – April 8, 2025 – Genomic Testing Cooperative (GTC) today announced it received UKCA marks for its Hematology Profile Plus, Solid Tumor
April 8, 2025 4:00 am
Press Releases
Labor Dr. Wisplinghoff and Genomic Testing Cooperative (GTC) Partner to Deploy GTC’s Comprehensive Suite of Tissue and Liquid Biopsy Testing for Solid Tumor and Hematologic Neoplasms in Germany
Cologne, Germany and Lake Forest, CA. USA, March 18, 2025 – Labor Dr. Wisplinghoff one of Germanys largest and most renowned medical laboratories and Genomic
March 18, 2025 4:00 am
Publications
mRNA Expression in DLBCL Patients who are CD20 Dim With an Eye Towards More Thoughtful Design of R/R Trials, Possibly Incorporating BCMA Bite Therapy
Bruce Hough, Maher Albitar Clinical Lymphoma, Myeloma and Leukemia, Vol. 000, No.xxx, 1–3 © 2025 Published by Elsevier Inc. Keywords: CD19 dim, Diffuse large b-cell
March 12, 2025 10:26 am
Publications
Next‑generation sequencing (NGS) detects presence of chimeric antigen receptor (CAR) T‑cell construct in a diffuse large B‑cell lymphoma patient with no response to CAR T‑cell therapy: a case report
Aishwarya Sridhar1 · Dylon Patel1 · Alexandra Della Pia2 · Tatyana A. Feldman2,3 · Lori A. Leslie2,3 · Andre H. Goy1,2 · Maher Albitar4 · Andrew Ip2,3Received: 27 June 2024 / Accepted: 19 November 2024© The Author(s) 2024 OPEN AbstractBackground CD19-directed chimeric antigen receptor
March 5, 2025 11:59 am
Publications
Updates on the Biological Heterogeneity of Mantle Cell Lymphoma
Andrew Ip 1,2,*,† , Maciej Kabat 3,† , Lindsay Fogel 1,4 , Hassan Alkhatatneh 5 , Jason Voss 2, Amolika Gupta 4,6,Alexandra Della Pia 2
February 27, 2025 11:27 am
Publications
cfDNA Chimerism and Somatic Mutation Testing in Early Prediction of Relapse After Allogeneic Stem Cell Transplantationfor Myeloid Malignancies
The research addresses the challenge of disease relapse, a primary cause of treatment failure post-hematopoietic stem cell transplantation. By employing next-generation sequencing of cfDNA to monitor donor cell chimerism and minimal residual disease (MRD) early after transplantation, the study identifies patients at increased risk of relapse. This approach allows for potential early intervention with consolidation therapy, aiming to mitigate the risk of treatment failure.
February 13, 2025 11:51 am
7th Annual Hematologic Malignancies Symposium and Genomics Workshop
The 7th Annual Hematologic Malignancies Symposium and Genomics Workshop offers a unique opportunity for healthcare professionals to deepen their understanding of cutting-edge research and clinical advancements in
January 8, 2025 10:51 am